MOUNTAIN VIEW, CA and TOKYO, JAPAN--(MARKET WIRE)--Aug 8, 2007 -- REGiMMUNE Corporation, a privately held biopharmaceutical company, announced today it has been awarded a grant from the Japanese Ministry of Economy, Trade and Industry (METI). REGiMMUNE received the grant under the METI-sponsored Regional New Consortium Projects/New Industry Creative-Type Technology R&D Promotion Programs, which is intended to promote new industries and new small businesses in Japan.
